Presence of the bcl-2 protein and apoptosis in non-Hodgkin lymphomas with diffuse growth pattern

Int J Cancer. 1995 Jun 9;61(6):826-31. doi: 10.1002/ijc.2910610614.

Abstract

In an attempt to further clarify the role of the apoptosis-counteracting protein bcl-2, non-Hodgkin lymphomas (NHL, n = 170) were examined immunohistochemically, across the boundaries of histologic classification, for the presence of this oncoprotein, in comparison with apoptotic indices (AI) and percentages of Ki-67+ cells (growth fraction). The results of this retrospective study revealed a highly significant inverse relationship ("mirror image") between the proportion of bcl-2+ cells and the AI per case. Both these parameters, although variable, clearly distinguished low- from high-grade-malignancy lymphomas according to the Kiel classification. Cluster analysis detected 2 separate groups of high-grade NHL, one with rather high AI and low percentages of bcl-2+ cells, comprising most anaplastic large-cell lymphomas, the other group with reverse characteristics. We found no correlation between the percentage of bcl-2+ cells per case and overall survival.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Apoptosis*
  • Cell Division
  • Humans
  • Immunohistochemistry
  • Lymphoma, Non-Hodgkin / chemistry*
  • Lymphoma, Non-Hodgkin / classification
  • Lymphoma, Non-Hodgkin / mortality
  • Lymphoma, Non-Hodgkin / pathology*
  • Proto-Oncogene Proteins / analysis*
  • Proto-Oncogene Proteins c-bcl-2
  • Retrospective Studies
  • Survival Analysis

Substances

  • Proto-Oncogene Proteins
  • Proto-Oncogene Proteins c-bcl-2